Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 1997

View Archived Issues

New indication for liquid Nutropin approved by FDA

Digital Gene Technologies and Recordati collaborate on atherosclerosis research

Cubist prepares inhibitors of isoleucyl-tRNA synthetase

Novel antifungal discovered by Takara Shuzo

Anticarcinogenic 2-thioflavones from Taiho

SS Pharm. discloses platinum complexes

Mitsubishi Chemical isolates antihypertensive compound from natural source

Thymosin alpha 1 for DiGeorge syndrome

Novo Nordisk discloses metabotropic glutamate receptor antagonists

Schering-Plough claims adenosine A2a antagonists

Budesonide cleared in Canada for Crohn's disease

Shire's sustained-release carbamazepine deemed approvable by FDA

Gene therapy for radiation-induced salivary gland defects

Novel drug delivery system from Brown University shows promise

Annual Report: Emisphere Technologies

Company Profile: SangStat

Enzymes for anticancer drug design discovered and characterized

Company Profile: Oncogene Science

PPL Therapeutics produces salmon calcitonin in transgenic rabbits

Cortecs reports results with potential new class of anticancer compounds

GEM-91 associated with up to 90% decrease in cellular viremia in HIV-positive patients

Cardiosol associated with improved survival and reduced rejection in heart transplantation

Targeted Genetics' AAV vector useful for in vivo cardiovascular gene therapy

Antiangiogenic antibody from Ixsys enters clinical trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...